Ogawa H, Konishi T, Najima Y, Kito S, Hashimoto S, Kato C, Sakai S, Kanbara Y, Atsuta Y, Konuma R, Wada A, Murakami D, Nakasima S, Uchibori Y, Onai D, Hamamura A, Nishijima A, Shingai N, Toya T, Shimizu H, Kobayashi T, Ohashi K, Doki N, Murofushi KN.

Phase I trial of myeloablative conditioning with 3-day total marrow and lymphoid irradiation for leukemia.